[KongchangAI]
Unverified85% confidenceDecision RuleTime unknown

如果追求更少的每日用药次数和更长效的控制,应优先考虑奥洛他定等双效抗过敏滴眼液(通常每日1-2次即可),而非依美斯汀

1
Sources
85%
Confidence
Long-term
Relevance
-
First Seen

Sources

Related Entities

Related Claims

Cite This Claim

Stable URI
https://kongchang.com/claim/771491
API
curl https://kongchang.com/api/v1/knowledge/claims/771491
MCP
get_claim(id=771491)